Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2000
10/12/2000WO2000038747A3 Absorbent article composition and method of use for sequestering skin irritants
10/12/2000WO2000037037A3 Composition for treatment of burns
10/12/2000WO2000035939A3 Connective tissue growth factor fragments and methods and uses thereof
10/12/2000WO2000025722A3 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS
10/12/2000WO2000017232A3 Regulatory protein from human keratinocytes
10/12/2000DE19915364A1 Verwendung von Arylalkanoylpyridazinen Use of Arylalkanoylpyridazinen
10/12/2000CA2373717A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2368686A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000CA2368493A1 Lta4 hydrolase inhibitors
10/12/2000CA2368240A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000CA2367378A1 Molecules of the immune system
10/12/2000CA2367051A1 Use of arylalkanoylpyridazines
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2365834A1 Herbal compositions and uses for the treatment of allergic reactions
10/12/2000CA2365500A1 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000CA2365421A1 Vesicle associated proteins
10/11/2000EP1043307A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
10/11/2000EP1043306A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
10/11/2000EP1043026A2 Melanoma therapy
10/11/2000EP1043023A1 Viscous compositions containing carbon dioxide
10/11/2000EP1042674A1 148 human secreted proteins
10/11/2000EP1042466A1 Polypeptides, polynucleotides and uses thereof
10/11/2000EP1042365A1 Compounds and methods for modulating occludin related tissue permeability
10/11/2000EP1042343A1 Vegi, an inhibitor of angiogenesis and tumor growth
10/11/2000EP1042329A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical, compositions containing them and use for preparing medicines
10/11/2000EP1042319A1 Dihydrobenzofurans
10/11/2000EP1042313A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity
10/11/2000EP1042307A1 Aminothiazole inhibitors of cyclin dependent kinases
10/11/2000EP1042297A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
10/11/2000EP1042279A1 Substituted beta-alanines
10/11/2000EP1042003A1 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
10/11/2000EP1041996A1 Keratinocyte growth factor-2 formulations
10/11/2000EP1041990A1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/11/2000EP1041979A1 Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof
10/11/2000EP1041977A1 USE OF PPAR-$g(g) ACTIVATORS IN DERMATOLOGY
10/11/2000EP1041970A1 Compositions of microspheres for wound healing
10/11/2000EP1041880A1 A delivery of arginine to cause beneficial effects
10/11/2000CN1269723A Maternal immue secretions and their use in treatment and/or prophylaxis of conditions of human body
10/11/2000CN1269715A Method and composition for treating late allergic reactions and inflammation diseases
10/11/2000CN1269236A External-use ointment for treating burns and scalds
10/11/2000CN1269225A Nevus eliminating ointment
10/11/2000CN1269212A Preparation of external-use Chinese medicine for chapped skin and chapped eczema
10/11/2000CN1057229C Beriberi medicine liquor and its preparation method
10/11/2000CN1057222C Medicinal decoction for diminishing freckles
10/11/2000CN1057218C Chinese medicine preparation for curing sore, ulcer and infection caused by external wound and preparation method thereof
10/11/2000CN1057215C Ointment for burns made of sausurea Involucrata
10/11/2000CN1057213C Chinese medicinal preparation for treating skin diseases
10/11/2000CN1057211C Toxin-resolving plaster for curing carbuncle, furuncle etc. and preparation method
10/10/2000US6130254 Methods for inhibiting photoaging of skin
10/10/2000US6130230 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof
10/10/2000US6130071 Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof
10/10/2000US6129913 Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
10/10/2000CA2183415C A new skin preparation composition
10/08/2000CA2303992A1 Melanoma therapy
10/07/2000CA2304127A1 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
10/07/2000CA2303721A1 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058506A2 Susceptibility to psoriasis
10/05/2000WO2000058496A1 50 human secreted proteins
10/05/2000WO2000058495A1 45 human secreted proteins
10/05/2000WO2000058494A1 50 human secreted proteins
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058468A2 47 human secreted proteins
10/05/2000WO2000058467A1 50 human secreted proteins
10/05/2000WO2000058466A2 Protease resistant flint analogs
10/05/2000WO2000058355A1 50 human secreted proteins
10/05/2000WO2000058350A1 49 human secreted proteins
10/05/2000WO2000058340A2 50 human secreted proteins
10/05/2000WO2000058334A1 50 human secreted proteins
10/05/2000WO2000058325A1 Bioprecursors of a retinoic derivative and pharmaceutical and/or cosmetic compositions
10/05/2000WO2000058318A1 Phosphate containing macrocyclic immunomodulators
10/05/2000WO2000058314A2 Sulfamate containing macrocyclic immunomodulators
10/05/2000WO2000058307A2 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
10/05/2000WO2000058305A1 Novel compounds
10/05/2000WO2000058295A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000WO2000058292A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
10/05/2000WO2000057920A2 Method for expressing proteins
10/05/2000WO2000057903A2 48 human secreted proteins
10/05/2000WO2000057901A1 Modulation of vascular permeability by means of tie2 receptor activators
10/05/2000WO2000057899A1 Thrombospondin-2 and uses thereof
10/05/2000WO2000057897A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000WO2000057889A1 Skin preparations for external use
10/05/2000WO2000057840A2 Dermatological topical composition
10/05/2000WO2000057836A2 Cosmetic or dermatological compositions containing at least one substance for increasing the functionality and/or expression of cd44 membrane receptors of skin cells
10/05/2000WO2000040217B1 Topical composition comprising n-acetylaldosamines or n-acetylamino acids
10/05/2000WO2000031280A3 Use of plus-strand synthesis elements in retroviral vectors
10/05/2000WO2000026243A3 Transmembrane 4 proteins
10/05/2000WO2000005249A3 Synthetic peptides and methods of use for autoimmune disease therapies
10/05/2000WO1999032135A8 Keratinocyte growth factor-2 formulations
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2370441A1 50 human secreted proteins
10/05/2000CA2369458A1 47 human secreted proteins
10/05/2000CA2368951A1 50 human secreted proteins
10/05/2000CA2368927A1 45 human secreted proteins
10/05/2000CA2368881A1 50 human secreted proteins
10/05/2000CA2368719A1 50 human secreted proteins
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368657A1 Thrombospondin-2 and uses thereof
1 ... 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 ... 1065